<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>NIDDK Current Funding Opportunities</title><link>https://www.niddk.nih.gov/research-funding/current-opportunities</link><description>All funding opportunities currently available from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</description><language>en</language><item><guid isPermaLink="false">{F70D49D0-9842-485F-A59E-F12CBE8B8892}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-184</link><title>Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)</title><description>The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.&lt;br /&gt;&lt;div style="text-align: left;"&gt;&lt;em&gt;Diabetes, Endocrinology, and Metabolic Diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:spainl@niddk.nih.gov?subject=PAR-24-184"&gt;Lisa M. Spain, Ph.D.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Digestive &amp;amp; Liver Diseases, Nutrition and Obesity:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:voula.osganian@nih.gov?subject=PAR-24-184"&gt;Voula Osganian, M.D., Sc.D., M.P.H&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Urologic Diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:rankint@mail.nih.gov?subject=PAR-24-184"&gt;Tracy L. Rankin, M.P.H.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Kidney Diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:raquel.greer@nih.gov?subject=PAR-24-184"&gt;Raquel Greer, M.D., M.H.S&lt;/a&gt;&lt;br /&gt;&lt;/div&gt; | PA-24-184</description><pubDate>Wed, 10 Apr 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{3C87FC37-1F9E-4F36-B748-A19A6886C6CB}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-185</link><title>Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)</title><description>The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.&lt;br /&gt;&lt;em&gt;Diabetes, Endocrinology, and Metabolic Diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:lisa.spain@nih.gov?subject=PA-24-185"&gt;Lisa M. Spain, Ph.D.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Digestive &amp;amp; Liver Diseases, Nutrition and Obesity:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:David.Saslowsky@nih.gov?subject=PA-24-185"&gt;David E. Saslowsky, Ph.D.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Neurobiology of digestive diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:diana.cummings@nih.gov?subject=PA-24-185"&gt;Diana Cummings, Ph.D.;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Genetics and genomics of digestive diseases&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:ludmila.pawlikowska@nih.gov?subject=PA-24-185"&gt;Ludmilla Pawlikowska, Ph.D&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Urologic Diseases&lt;/em&gt;:&lt;br /&gt;&lt;a href="mailto:rankint@niddk.nih.gov?subject=PA-24-185"&gt;Tracy L. Rankin, M.P.H.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Kidney Diseases:&lt;/em&gt;&lt;br /&gt;&lt;a href="mailto:raquel.greer@nih.gov?subject=PA-24-185"&gt;Raquel Greer, M.D., M.H.S&lt;/a&gt;&lt;br /&gt; | PA-24-185</description><pubDate>Tue, 09 Apr 2024 12:04:19 -0400</pubDate></item><item><guid isPermaLink="false">{0923E583-46B1-45ED-A246-A06D64C76CE7}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-25-009</link><title>Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)</title><description>This NOFO encourages applications from institutions that propose to establish research experiences in kidney technology development. Successful programs should include a collaborative capstone research or design project(s), innovative and/or ground-breaking technology development, multidisciplinary/interdisciplinary teamwork, education in entrepreneurship, product development and navigating regulatory pathways, and clinical immersion. Applications must include plans to recruit undergraduate students as participants and to engage students from engineering and other quantitative scientific and technical backgrounds, but applicants may also propose the inclusion of medical students, graduate students and/or dual-degree students (e.g., M.D./Ph.D.; Pharm.D./Ph.D.) prior to their qualifying exams and selection of Ph.D. mentor.&lt;br /&gt;&lt;a href="mailto:daniel.gossett@nih.gov?subject=RFA-DK-25-009"&gt;Daniel Gossett, Ph.D.&lt;/a&gt;;&lt;a href="mailto:rankint@nih.gov?subject=RFA-DK-25-009"&gt;Tracy L. Rankin, Ph.D., M.P.H.&lt;/a&gt; | RFA-DK-25-009</description><pubDate>Wed, 03 Apr 2024 10:56:27 -0400</pubDate></item><item><guid isPermaLink="false">{80F8603A-0466-4F4B-B010-3D2B1A2324D2}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-206</link><title>Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)</title><description>The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.&lt;br /&gt;&lt;a href="mailto:cindy.roy@nih.gov?subject=PAR-24-206"&gt;Cindy Roy, Ph.D&lt;/a&gt; | PAR-24-206</description><pubDate>Tue, 02 Apr 2024 11:27:01 -0400</pubDate></item><item><guid isPermaLink="false">{3C79559C-1CFE-4D8B-AD4E-296AE70EED69}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-24-002</link><title>Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)</title><description>The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.&lt;br /&gt;&lt;a href="mailto:arreazag@mail.nih.gov?subject=RFA-DK-24-002"&gt;Guillermo Arreaza-Rubin, M.D.&lt;/a&gt; | RFA-DK-24-002</description><pubDate>Mon, 01 Apr 2024 13:39:16 -0400</pubDate></item><item><guid isPermaLink="false">{2A235998-E459-49CB-B147-B8ED9F82AC3A}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-25-008</link><title>Diabetes Research Centers (P30 Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. &lt;br/&gt;This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.&lt;br /&gt;&lt;a href="mailto:silvacm@mail.nih.gov?subject=RFA-DK-25-008"&gt;Corinne M. Silva, Ph.D.&lt;/a&gt; | RFA-DK-25-008</description><pubDate>Mon, 01 Apr 2024 11:49:07 -0400</pubDate></item><item><guid isPermaLink="false">{621C4B12-F11D-4F1D-A713-129C8EEC57E3}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-23-007</link><title>Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)</title><description>This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.&lt;br /&gt;&lt;a href="mailto:blondelol@niddk.nih.gov?subject=RFA-DK-23-007"&gt;Olivier Blondel, Ph.D.&lt;/a&gt; | RFA-DK-23-007</description><pubDate>Mon, 01 Apr 2024 11:43:00 -0400</pubDate></item><item><guid isPermaLink="false">{0660D0A7-0457-4E46-BF47-6E398C2EE5E8}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-24-078</link><title>Notice of Special Interest (NOSI): Supporting the Exploration of Cloud in NIH-supported Research</title><description>This notice announces the availability of funds from the Office of Data Science Strategy (ODSS) to NIH-managed or NIH-majority-funded projects that may benefit from using the cloud. The purpose of this announcement is to explore and test potential opportunities for leveraging cloud solutions to enhance existing NIH activities.  Projects already using cloud may apply to explore and test cloud capabilities not yet leveraged. This initiative is aligned with the NIH Strategic Plan for Data Science, which describes actions aimed at building a better data infrastructure and a modernized data ecosystem.&lt;br /&gt;&lt;a href="mailto:cloudsupport@nih.gov?subject=NOT-OD-24-078"&gt;Fenglou Mao&lt;/a&gt; | NOT-OD-24-078</description><pubDate>Wed, 27 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{58F1FC78-764A-4890-87BB-5253C57DDF66}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-ns-25-012</link><title>HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)</title><description>This notice of funding opportunity (NOFO) aims to encourage research grant applications for initial translational efforts that will enable a drug discovery program for novel, non-opioid, and non-addictive treatments for pain. The program provides funding to develop and validate assays to support a distinct testing funnel and conduct screening efforts to identify and characterize potential therapeutic agents including small molecules, biologics, and natural products. Preliminary in vivo pharmacokinetic, pharmacodynamic, and efficacy studies may also be supported. The goal of this NOFO is to advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program or other later-stage translational programs.&lt;br /&gt;&lt;a href="mailto:andersendk@mail.nih.gov?subject=RFA-NS-25-012"&gt;Dana K Andersen, MD&lt;/a&gt; | RFA-NS-25-012</description><pubDate>Tue, 26 Mar 2024 12:56:45 -0400</pubDate></item><item><guid isPermaLink="false">{9E1A507C-E42E-437D-A323-18989BC108FE}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-24-079</link><title>Notice of Special Interest: Womens Health Research</title><description>In alignment with the White House Initiative on Women’s Health Research, the National Institutes of Health (NIH) is issuing this Notice of Special Interest to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause).&lt;br/&gt;&lt;br/&gt;For consideration under this NOSI, applications must have a central focus on the health of women, as demonstrated through specific aims that EITHER explicitly address a particular condition in women OR focus on one of the high priority topics below. In either approach, intersectional and/or multidimensional approaches that consider the health of women in context (e.g., projects accounting for social and structural variables—including race, ethnicity, socioeconomic status , and State and Federal policies— that affect women’s health) are strongly encouraged. For consideration under this NOSI, projects are not required to exclusively focus on women. However, studies that include more than one sex or gender should be designed and powered to make generalizable conclusions about women and enable sex or gender difference comparison.&lt;br /&gt;&lt;a href="mailto:christine.maric-bilkan@nih.gov?subject=NOT-OD--24-079"&gt;Christine Maric-Bilkan, Ph.D&lt;/a&gt;.; &lt;a href="mailto:katrina.serrano@nih.gov?subject=NOT-OD--24-079"&gt;Katrina Serrano, Ph.D.&lt;/a&gt; | NOT-OD-24-079</description><pubDate>Tue, 26 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{81AC5DA3-0862-4C8E-A97A-7AFA560B9246}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-018</link><title>Request for Information (RFI): Inviting Comments and Feedback on the National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic, and Hematologic Diseases Institutional Network Award (U2C-TL1)</title><description>The Division of Kidney, Urologic, and Hematologic Diseases (KUH) within the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking input on potential programmatic changes to the Institutional Network Award program solicited by NOFOs PAR-20-220 and PAR-23-248&lt;br /&gt;&lt;p&gt;&lt;a href="mailto:rankint@nih.gov"&gt;Tracy L. Rankin, Ph.D., M.P.H.&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="mailto:christine.maric-bilkan@nih.gov"&gt;Christine Maric-Bilkan, Ph.D.&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="mailto:anna.sadusky@nih.gov"&gt;Anna Sadusky, Ph.D.&lt;/a&gt;&lt;br /&gt;&lt;/p&gt; | NOT-DK-24-018</description><pubDate>Tue, 19 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{845EF4FE-E399-44FA-A57C-D4F104689BBE}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-162</link><title>Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)</title><description>This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues are important for developing strategies for long-term viral suppression or eradication. Finally, health-impeding social determinants of health may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=PAR-24-162"&gt;Peter J. Perrin, Ph.D.&lt;/a&gt;; &lt;a href="mailto:Deepak.Nihalani@nih.gov?subject=PAR-24-162"&gt;Deepak Nihalani, Ph.D.&lt;/a&gt;; &lt;a href="mailto:sm007@nih.gov?subject=PAR-24-162"&gt;Saul Malozowski, M.D, Ph.D., M.B.A.&lt;/a&gt; | PAR-24-162</description><pubDate>Mon, 18 Mar 2024 11:56:36 -0400</pubDate></item><item><guid isPermaLink="false">{F3CE02DE-DA04-41D4-812B-0CB60327AF6D}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-144</link><title>Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)</title><description>The SuRE program supports research capacity building at eligible higher education institutions bythrough funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. &lt;br/&gt;The purpose of SuRE awards is to provide research grant support for faculty investigators at resource-limited institutions who are not currently funded by any NIH Research Project Grants (RPGs) - with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences and to enhance the institutional scientific research culture.&lt;br /&gt;&lt;a href="mailto:katrina.serrano@nih.gov?subject=PAR-24-144"&gt;Katrina Jane Serrano, Ph.D.&lt;/a&gt; | PAR-24-144</description><pubDate>Thu, 14 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{0E049CBC-CEDC-425E-86A3-2DBB2F13B2E5}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-145</link><title>Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)</title><description>The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research in basic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. &lt;br/&gt;The purpose of SuRE-First awards is to provide research grant support for faculty investigators who have not had prior independent external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences and to enhance the institutional scientific research culture.&lt;br /&gt;&lt;a href="mailto:katrina.serrano@nih.gov?subject=PAR-24-145"&gt;Katrina Jane Serrano, Ph.D.&lt;/a&gt; | PAR-24-145</description><pubDate>Thu, 14 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{5DBEB765-7FAF-451F-A55E-32715FF89D37}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-md-24-006</link><title>Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.&lt;br /&gt;&lt;a href="mailto:daniel.gossett@nih.gov?subject=RFA-MD-24-006"&gt;Daniel Gossett, Ph.D.&lt;/a&gt; | RFA-MD-24-006</description><pubDate>Fri, 08 Mar 2024 15:00:09 -0500</pubDate></item><item><guid isPermaLink="false">{E0CCBCB7-94B9-411E-BA1B-404BA24247D8}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-141</link><title>NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)</title><description>The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.&lt;br /&gt;&lt;a&gt;NIDDK_R13@niddk.nih.gov&lt;/a&gt;&lt;span style="background-color: #e7e9ea; color: #3b3b3b;"&gt;&lt;/span&gt; | PA-24-141</description><pubDate>Wed, 06 Mar 2024 15:42:02 -0500</pubDate></item><item><guid isPermaLink="false">{2D7C13E8-CE90-4641-B73A-A165BA88F645}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-md-24-005</link><title>Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)</title><description>The purpose of this initiative is to support research to determine the underlying mechanisms that contribute to health disparities in HIV and aging and how multiple comorbidities influence overall health outcomes and quality of life among people with HIV from populations that experience health disparities.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=RFA-MD-24-005"&gt;Peter J Perrin, Ph.D.&lt;/a&gt; | RFA-MD-24-005</description><pubDate>Fri, 01 Mar 2024 12:52:48 -0500</pubDate></item><item><guid isPermaLink="false">{88F3B0BA-B5E6-472B-AF08-B2AA4F8BBB75}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-015</link><title>Notice of Special Interest (NOSI): Encouraging Health Disparities and Health Equity Workforce Development within NIDDK Mission Areas</title><description>The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is issuing this Notice of Special Interest (NOSI) to stimulate workforce development in biomedical research areas to eliminate health disparities and improve health equity within the scope of NIDDK’s mission diseases and conditions. NIDDK conducts and supports research and research training to improve health and quality of life for people with diabetes and other endocrine and metabolic disorders; liver, intestinal, and other digestive diseases; obesity; nutritional disorders; and kidney, urologic, and hematologic diseases. Many of these diseases and conditions disproportionately affect racial and ethnic minority populations and others who are medically underserved. &lt;br /&gt;&lt;p&gt;Please direct all inquiries to the Scientific/Research, Peer Review, and Financial/Grants Management contacts in Section VII of the listed notice of funding opportunity.&lt;/p&gt; | NOT-DK-24-015</description><pubDate>Fri, 01 Mar 2024 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{473AB065-8A86-4F06-B28F-678C7649B13A}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pas-24-163</link><title>Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=PAS-24-163"&gt;Peter J. Perrin, Ph.D.&lt;/a&gt;; &lt;a href="mailto:Deepak.Nihalani@nih.gov?subject=PAS-24-163"&gt;Deepak Nihalani, Ph.D.&lt;/a&gt;; &lt;a href="mailto:sm007@nih.gov?subject=PAS-24-163"&gt;Saul Malozowski, M.D., Ph.D., M.B.A.&lt;/a&gt; | PAS-24-163</description><pubDate>Thu, 29 Feb 2024 16:43:48 -0500</pubDate></item><item><guid isPermaLink="false">{EC207EC7-3900-4B9B-A005-D61068293239}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-25-013</link><title>Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)</title><description>This Notice of Funding Opportunity (NOFO) seeks to foster new multi-disciplinary teams to address how HIV Comorbidities and co-infections within the missions of NIDDK and NIAID interact with viral reservoirs, potentially confounding cure strategies aimed at either sustained viral suppression or elimination from the body. These teams will mechanistically interrogate the impact of inflammation, metabolic perturbations, or other pathophysiological processes associated with these comorbidities or co-infections on reservoir dynamics, and/or the interplay of these conditions and co-infections on HIV reservoir biology in ways that are likely to interact with potential cure strategies.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=RFA-DK-25-013"&gt;Peter J. Perrin, Ph.D.;&lt;/a&gt;&lt;a href="mailto:Deepak.Nihalani@nih.gov?subject=RFA-DK-25-013"&gt;Deepak Nihalani, Ph.D.&lt;/a&gt;;&lt;a href="mailto:sm007@nih.gov?subject=RFA-DK-25-013"&gt;Saul Malozowski, M.D, Ph.D., M.B.A.&lt;/a&gt; | RFA-DK-25-013</description><pubDate>Thu, 29 Feb 2024 09:33:31 -0500</pubDate></item><item><guid isPermaLink="false">{634312D3-E210-4E4B-9A69-B59E8310DA9E}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-010</link><title>Notice of Special Interest (NOSI): Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed)</title><description>NIDDK aims to achieve equitable engagement in research across all persons impacted by type 1 diabetes (T1D). Understanding that participation in research is inequitable across many groups impacted by T1D, this supplement opportunity supports activities which enhance outreach to and engagement with underserved populations which experience diabetes-related health disparities. (ref. NIH designated health disparities populations). Improved engagement, participation, and incorporation of leadership from underserved T1D populations is deemed essential for addressing disparities and advancing health equity in T1D outcomes.&lt;br/&gt;&lt;br/&gt;This supplement opportunity is available to PD(s)/PI(s) of active NIDDK research grants investigating T1D. Administrative supplements must support work within the scope of the original project and cannot be used to support planning activities for future grants.&lt;br /&gt;&lt;a href="mailto:Miranda.Broadney@nih.gov?subject=NOT-DK-24-010"&gt;Miranda M. Broadney MD, MPH&lt;/a&gt; | NOT-DK-24-010</description><pubDate>Fri, 16 Feb 2024 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{E2F7300C-36BD-40E9-A536-9EF6E505A206}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-23-011</link><title>Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)</title><description>Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving technology that could be utilized clinically to prevent DKA by an early warning of elevations in ketone levels.The purpose of this NOFO is to solicit applications for studies that will develop and test risk mitigation strategies that involve the clinical integration of CKM for the safe use of SGLT2i for people living with T1D so that they may benefit from the cardiac and renal protection and glucose-lowering effects of this drug class. The NOFO will support short-term, clinical trials to gain and disseminate knowledge on safety and glucose control with CKM and SGLT2i use.Possible topics include testing optimal insulin delivery in open and closed loop systems or multiple daily injections and developing clinical protocols to control or ameliorate elevated ketone levels in individuals with T1D who are receiving adjunct therapy with SGLT2i.&lt;br /&gt;&lt;a href="mailto:teresa.jones@nih.gov?subject=RFA-DK-23-011"&gt;Teresa L. Z. Jones, M.D.&lt;/a&gt;; &lt;a href="mailto:guillermo.arreaza-rubin@nih.gov?subject=RFA-DK-23-011"&gt;Guillermo Arreaza Rubin, M.D.&lt;/a&gt; | RFA-DK-23-011</description><pubDate>Tue, 30 Jan 2024 14:42:14 -0500</pubDate></item><item><guid isPermaLink="false">{3FFF4F1D-1836-4B22-8664-E5E7BCC39B3B}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-103</link><title>NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)</title><description>This NOFO invites applications for investigator-initiated, high-risk multi-center clinical trials involving more than one clinical center. Proposed trials should be hypothesis-driven, have the potential to change clinical practice and/or public health, and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.&lt;br/&gt;&lt;br/&gt;This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation.  Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.&lt;br /&gt;&lt;a href="mailto:rankint@mail.nih.gov?subject=PAR-24-103"&gt;Tracy Rankin, Ph.D., M.P.H.&lt;/a&gt;; &lt;a href="mailto:linderb@mail.nih.gov?subject=PAR-24-103"&gt;Barbara Linder, M.D., Ph.D.&lt;/a&gt;; &lt;a href="mailto:aynur.unalp-arida@nih.gov?subject=PAR-24-103"&gt;Aynur Unalp-Arida, M.D., Ph.D.&lt;/a&gt; | PAR-24-103</description><pubDate>Thu, 04 Jan 2024 12:56:06 -0500</pubDate></item><item><guid isPermaLink="false">{C7EBF732-56BC-480A-95DD-1DD06B93AA2F}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-102</link><title>NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)</title><description>This NOFO invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research Staff strongly encouraged prior to the submission of either a U34 or U01 application.&lt;br/&gt;&lt;br/&gt;This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation.  Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.&lt;br /&gt;&lt;a href="mailto:rankint@mail.nih.gov?subject=PAR-24-103"&gt;Tracy Rankin, Ph.D., M.P.H.&lt;/a&gt;;&lt;a href="mailto:linderb@mail.nih.gov?subject=PAR-24-103"&gt;Barbara Linder, M.D., Ph.D.&lt;/a&gt;;&lt;a href="mailto:aynur.unalp-arida@nih.gov?subject=PAR-24-103"&gt;Aynur Unalp-Arida, M.D., Ph.D.&lt;/a&gt; | PAR-24-102</description><pubDate>Thu, 04 Jan 2024 12:27:19 -0500</pubDate></item><item><guid isPermaLink="false">{0C7904A5-06C1-4E4C-8F6A-0C227F2B41DD}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-094</link><title>NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)</title><description>NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.&lt;br /&gt;&lt;a href="mailto:rankint@mail.nih.gov?subject=PAR-24-103"&gt;Tracy Rankin, Ph.D., M.P.H.&lt;/a&gt;;&lt;a href="mailto:linderb@mail.nih.gov?subject=PAR-24-103"&gt;Barbara Linder, M.D., Ph.D.&lt;/a&gt;;&lt;a href="mailto:aynur.unalp-arida@nih.gov?subject=PAR-24-103"&gt;Aynur Unalp-Arida, M.D., Ph.D.&lt;/a&gt; | PAR-24-094</description><pubDate>Thu, 04 Jan 2024 12:09:22 -0500</pubDate></item><item><guid isPermaLink="false">{9AB90BE0-E784-4478-AD6F-86EA496C669C}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-075</link><title>Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)</title><description>The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.&lt;br /&gt;&lt;a href="mailto:shilpam.hattangadi@nih.gov?subject=PAR-24-075"&gt;Shilpa Manohar Hattangadi, MD&lt;/a&gt;; &lt;a href="mailto:anna.sadusky@nih.gov?subject=PAR-24-075"&gt;Anna Burkart Sadusky, PhD&lt;/a&gt; | PAR-24-075</description><pubDate>Fri, 22 Dec 2023 11:38:25 -0500</pubDate></item><item><guid isPermaLink="false">{6BECE443-85D8-44C9-A51D-141D1CE3B64F}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-074</link><title>NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)</title><description>The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.&lt;br/&gt;To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on:&lt;br/&gt;Courses for Skills Development&lt;br/&gt;Research Experiences&lt;br/&gt;These courses for skill development and research experiences must fall within NIDDK's mission areas. NIDDK supports research training skill development and research experiences on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases. Please refer to the NIDDK website for more information.&lt;br /&gt;&lt;a href="mailto:%20david.saslowsky@nih.gov?subject=PAR-24-074"&gt;David Saslowsky, Ph.D&lt;/a&gt;&lt;a href="mailto:castlea@mail.nih.gov?subject=Par-24-074"&gt;Arthur Castle, Ph.D&lt;/a&gt;&lt;a href="mailto:rankint@niddk.nih.gov?subject=PAR-24-074"&gt;Tracy Rankin, PhD, M.P.H&lt;/a&gt; | PAR-24-074</description><pubDate>Thu, 21 Dec 2023 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{B0AC02DA-79A5-483F-92EB-3A22E1F581CC}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-007</link><title>Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases</title><description>This NOSI invites applications for research to understand and mitigate health disparities in the prevention, development, diagnosis, treatment and progression of diseases and conditions of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It is recognized that health disparities are driven by factors operating at multiple levels (i.e., individual, interpersonal, community, societal) and domains (e.g., biological, behavioral, sociocultural, physical/built environment, etc.) and interacting in complex ways. (Refer to the NIMHD Minority Health and Health Disparities Research Framework.)&lt;br /&gt;Please direct all inquiries to the Scientific/Research, Peer Review, and Financial/Grants Management contacts in Section VII of the listed notice of funding opportunity.&lt;p /&gt; | NOT-DK-24-007</description><pubDate>Wed, 20 Dec 2023 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{6E0C7C2F-8D4E-4085-92DA-F27BFF320ACC}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-24-040</link><title>Notice of Special Interest (NOSI): Research Council of Finland (RCF) National Institutes of Health (NIH) Partnership Program</title><description>The purpose of this Notice of Special Interest (NOSI) is to alert the community about, and disseminate knowledge and information regarding a program fostering the expansion of U.S.-Finland biomedical and behavioral research collaboration. This NOSI replaces the former NOT-OD-21-021.&lt;br /&gt;&lt;a href="mailto:sarah.scharf@nih.gov?subject=NOT-OD-24-040"&gt;Sarah Scharf, MPA&lt;/a&gt; | NOT-OD-24-040</description><pubDate>Thu, 14 Dec 2023 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{AA4C21A1-E688-4EFF-B1CA-0EE728CD0713}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-091</link><title>Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)</title><description>This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:&lt;br/&gt;1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and&lt;br/&gt;2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.&lt;br/&gt;Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=PAR-24-091"&gt;Peter J Perrin, Ph.D.&lt;/a&gt; | PAR-24-091</description><pubDate>Mon, 11 Dec 2023 14:22:00 -0500</pubDate></item><item><guid isPermaLink="false">{4C8626B2-B550-410B-A27F-630AD965864B}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-092</link><title>Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)</title><description>This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:&lt;br/&gt;1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and&lt;br/&gt;2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.&lt;br/&gt;Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.&lt;br /&gt;&lt;a href="mailto:peter.perrin@nih.hhs.gov?subject=PAR-24-092"&gt;Peter J Perrin, Ph.D.&lt;/a&gt; | PAR-24-092</description><pubDate>Mon, 11 Dec 2023 14:20:08 -0500</pubDate></item><item><guid isPermaLink="false">{CEA832A1-FC28-4D46-9360-3D8CCCA4E063}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-25-001</link><title>Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites research projects that seek solutions to the development, exacerbation, and ineffective management of co-occurring conditions in marginalized communities of People with HIV (PWH). Projects must be based on a syndemics (synergistic epidemic) framework with a focus on the impact of racism, marginalization, discrimination, and/or stigma and their inter-relationships with social and structural risks. Projects may use mechanistic interventional approaches, policy/program evaluation studies, or epidemiology studies that build the evidence base to support improved equity and outcomes. The co-occurring conditions must be within the mission of NIDDK or NHLBI.&lt;br /&gt;&lt;a href="mailto:Peter.Perrin@nih.gov?subject=RFA-DK-25-001"&gt;Peter Perrin, Ph.D.&lt;/a&gt;; &lt;a href="mailto:Shavon.Dickerson@nih.gov?subject=RFA-DK-25-001"&gt;Shavon Artis Dickerson, Dr.P.H., M.P.H.&lt;/a&gt;; &lt;a href="mailto:Jenna.Norton@nih.gov?subject=RFA-DK-25-001"&gt;Jenna Norton, Ph.D., M.P.H.&lt;/a&gt; | RFA-DK-25-001</description><pubDate>Thu, 30 Nov 2023 13:44:40 -0500</pubDate></item><item><guid isPermaLink="false">{0099BF3B-F8B9-4FDB-873E-BDA470A6509B}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-077</link><title>Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)</title><description>The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative observational and intervention-based research to identify and characterize the pathways and mechanisms through which health and health care disparities occur among sexual and gender minority populations of minoritized racial/ethnic and socio-economic statuses.&lt;br /&gt;PAR-24-077</description><pubDate>Thu, 30 Nov 2023 11:38:37 -0500</pubDate></item><item><guid isPermaLink="false">{7C419B25-0BAD-4C63-B3FD-BE23AA6488D0}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-317</link><title>Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)</title><description>The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision Notice of Special Interest (NOSI). Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this NOFO.&lt;br /&gt;PA-23-317</description><pubDate>Fri, 24 Nov 2023 11:17:59 -0500</pubDate></item><item><guid isPermaLink="false">{4C648B49-F9DE-407A-9BE3-86F285679946}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-ns-24-019</link><title>HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)</title><description>Reissue of RFA-NS-20-010: The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials. Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent. The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application. This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.&lt;br /&gt;&lt;span&gt;&lt;a href="mailto:andersendk@mail.nih.gov?subject=RFA-NS-24-019"&gt;Dana K Andersen, M.D&lt;/a&gt;&lt;/span&gt; | RFA-NS-24-019</description><pubDate>Tue, 31 Oct 2023 11:52:36 -0400</pubDate></item><item><guid isPermaLink="false">{EF17EFBE-25AC-4C25-B47E-BCAF91B84CD3}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-dk-25-003</link><title>Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases within the NIDDK's mission. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission ofthe NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.&lt;br /&gt;&lt;a href="mailto:peter.perrin@nih.gov?subject= RFA-DK-25-003 "&gt;Peter Perrin Ph.D.&lt;/a&gt; | RFA-DK-25-003</description><pubDate>Thu, 19 Oct 2023 13:17:55 -0400</pubDate></item><item><guid isPermaLink="false">{A9865CC9-D6CE-4AB4-8F61-7369B5907BD2}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-275</link><title>NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)</title><description>The purpose of this notice of funding opportunity (NOFO) is to encourage  researchers from diverse backgrounds to work with their institutions to submit applications for research projects within the mission of either NIAID or NIDDK. This NOFO seeks to support either (a) a New Investigator (NI), who has not previously competed successfully for substantial, independent funding from NIH, or (b) an 'At-Risk' investigator, who had prior support as a PD/PI on a substantial independent research award and unless successful in securing a substantial research grant award in the current fiscal year, will have no substantial research grant funding in the following fiscal year.&lt;br /&gt;&lt;a href="mailto:jenna.norton@nih.gov?subject=PAR-23-275"&gt;Jenna Norton, PhD, MPH&lt;/a&gt;; &lt;a href="mailto:raquel.greer@nih.gov?subject=PAR-23-275"&gt;Raquel Greer, MD, MHS&lt;/a&gt;; &lt;a href="mailto:evansmary@niddk.nih.gov?subject=PAR-23-275"&gt;Mary Evans, Ph.D.&lt;/a&gt;; &lt;a href="mailto:peter.perrin@nih.gov?subject=PAR-23-275"&gt;Peter Perrin, Ph.D.&lt;/a&gt;; &lt;a href="mailto:lisa.spain@nih.gov?subject=PAR-23-275"&gt;Lisa Spain, Ph.D.&lt;/a&gt; | PAR-23-275</description><pubDate>Wed, 13 Sep 2023 15:46:11 -0400</pubDate></item><item><guid isPermaLink="false">{139510B9-77C4-4480-B08E-12BEC547C377}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-271</link><title>Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)</title><description>The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.&lt;br/&gt;Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist.   &lt;br/&gt;This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.&lt;br /&gt;&lt;a href="mailto:riversrc@mail.nih.gov?subject=PA-23-271"&gt;Rob Rivers, Ph.D.&lt;/a&gt; | PA-23-271</description><pubDate>Tue, 12 Sep 2023 11:12:43 -0400</pubDate></item><item><guid isPermaLink="false">{04E0D609-85A7-4DB6-90D5-060CC157BE8F}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-298</link><title>Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)</title><description>The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to identify and rigorously test culturally appropriate solutions to reduce morbidity and mortality. Interventions should be designed with a consideration for sustainability within the communities where they are tested, and have the flexibility to be readily adapted, disseminated, and scaled up to other communities where culturally appropriate. This NOFO is part of the Intervention Research to Improve Native American Health (IRINAH) initiative, which also includes NOFOs using the R21 Exploratory/Developmental Research Grant mechanism (PAR-23-299) and the Clinical Trial Planning Grant mechanism (PAR-23-285). &lt;br /&gt;&lt;a href="mailto:evansmary@mail.nih.gov?subject=PAR-23-298"&gt;Mary Evans, Ph.D.&lt;/a&gt; | PAR-23-298</description><pubDate>Mon, 11 Sep 2023 14:32:07 -0400</pubDate></item><item><guid isPermaLink="false">{68C8216C-23F0-4B50-97FE-E81F4AA45E06}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-262</link><title>Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)</title><description>The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers.  Applications are expected to incorporate exceptional mentorship. &lt;br/&gt;This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.&lt;br /&gt;&lt;a href="mailto:CastleA@mail.nih.gov?subject=PA-23-262"&gt;Arthur L. Castle, Ph.D.&lt;/a&gt;; &lt;a href="mailto:DensmoreC@mail.nih.gov?subject=PA-23-262"&gt;Christine Densmore, M.S.&lt;/a&gt;; &lt;a href="mailto:%20Christine.maric-bilkan@nih.gov?subject=PA-23-262"&gt;Christine Maric-Bilkan, Ph.D.&lt;/a&gt;; &lt;a href="mailto:Cindy.Roy@nih.gov?subject=PA-23-262"&gt;Cindy N. Roy, Ph.D.&lt;/a&gt; | PA-23-262</description><pubDate>Thu, 07 Sep 2023 15:30:57 -0400</pubDate></item><item><guid isPermaLink="false">{65C02079-2B97-4C82-AD15-320CE4A41F1B}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-261</link><title>Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)</title><description>This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist.&lt;br/&gt;This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.&lt;br /&gt;&lt;a href="mailto:CastleA@mail.nih.gov?subject=PA-23-262"&gt;Arthur L. Castle, Ph.D.&lt;/a&gt;;&lt;a href="mailto:DensmoreC@mail.nih.gov?subject=PA-23-262"&gt;Christine Densmore, M.S.&lt;/a&gt;;&lt;a href="mailto:%20Christine.maric-bilkan@nih.gov?subject=PA-23-262"&gt;Christine Maric-Bilkan, Ph.D.&lt;/a&gt;;&lt;a href="mailto:Cindy.Roy@nih.gov?subject=PA-23-262"&gt;Cindy N. Roy, Ph.D.&lt;/a&gt; | PA-23-261</description><pubDate>Thu, 07 Sep 2023 15:22:18 -0400</pubDate></item><item><guid isPermaLink="false">{621455C0-4A0C-4F8A-9C03-2DC5C535F382}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-23-170</link><title>Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)</title><description>The goal of this NOSI is to provide information to the extramural community regarding an administrative supplement to provide full or part-time mentored research training experiences for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career after an interruption for family responsibilities or other qualifying circumstances as described below. The supplement grants are intended to provide these scientists with an opportunity to update or extend their research skills and knowledge and prepare them to re-establish or revitalize their careers in basic biomedical, behavioral, clinical, translational, or social science research. It is anticipated that by the completion of the supplement support period, the  awardee will be prepared to apply for a fellowship (F), career development (K) award, a research award (R), SBIR/STTR, or other types of independent research support. &lt;br /&gt;&lt;a href="mailto:xenia.tigno@nih.gov?subject=NOT-OD-23-170"&gt;Xenia T. Tigno, Ph.D., M.S.&lt;/a&gt; | NOT-OD-23-170</description><pubDate>Wed, 06 Sep 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{DE480A29-44F9-49C2-9568-97C8DD205C85}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-237</link><title>Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)</title><description>The purpose of this Notice of Funding Opportunity (NOFO) is to support established biomedical data resources, that have demonstrated impact and have potential for continued benefit to the mission of one or more of the NIH Institutes and Centers participating in this announcement.&lt;br/&gt;Each application must: (a) deliver scientific impact to the communities served; (b) employ and promote good data management practices (as outlined by the FAIR Data Principles including adherence to the NIH desirable characteristics of repositories) and efficient operations for quality and services; (c) engage with the user community and continuously address their needs; and (d) support a process for data life-cycle analysis, long-term preservation, and trustworthy governance. &lt;br/&gt;The evaluation of the repositories will be based on their usage, utility, impact, quality of data and services, and efficiency of operations, community needs and engagement, trustworthiness of stewardship, and governance.&lt;br /&gt;PAR-23-237</description><pubDate>Wed, 30 Aug 2023 09:20:44 -0400</pubDate></item><item><guid isPermaLink="false">{02AFE65E-A033-43F7-995E-1FD9154065F2}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-23-166</link><title>Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations</title><description>The mission of the NIH is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The NIH is committed to supporting research that will increase scientific understanding of health and well-being and lead to the development of effective evidence-based strategies, interventions, and services for people of all ages and backgrounds. NIH places a high priority on research with individuals and populations at increased risk for adverse health outcomes, and especially those who have received insufficient attention from the scientific research enterprise. To this end, and in response to Executive Order 14075 on Advancing Equality for Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex Individuals, this Notice of Special Interest (NOSI) announces an interest in research on the impact and consequences of family support and family rejection on the health and well-being of sexual and gender minority (SGM, defined for NIH purposes in NOT-OD-19-139) individuals across the life course. &lt;br /&gt;&lt;a href="mailto:Bonnie.Burgess-Beusse@nih.gov?subject=NOT-OD-23-166"&gt;Bonnie Burgess-Beusse, Ph.D.&lt;/a&gt; | NOT-OD-23-166</description><pubDate>Mon, 28 Aug 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{0D3D551A-F7ED-4116-B79F-A957885375A7}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-272</link><title>Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)</title><description>The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidates dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist.&lt;br/&gt;This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.&lt;br /&gt;&lt;a href="mailto:castlea@mail.nih.gov?subject=PA-23-272"&gt;Arthur Castle, Ph.D.&lt;/a&gt;; &lt;a href="mailto:densmorec@mail.nih.gov?subject=PA-23-272"&gt;Christine L Densmore, M.S.&lt;/a&gt;; &lt;a href="mailto:christine.maric-bilkan@nih.gov?subject=PA-23-272"&gt;Christine Maric-Bilkan, Ph.D.&lt;/a&gt;; &lt;a href="mailto:cindy.roy@nih.gov?subject=PA-23-272"&gt;Cindy Roy, Ph.D.&lt;/a&gt; | PA-23-272</description><pubDate>Wed, 16 Aug 2023 14:43:25 -0400</pubDate></item><item><guid isPermaLink="false">{241A7BB3-587C-414F-B30C-8D978A2DB139}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-260</link><title>Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)</title><description>This Notice of Funding Opportunity (NOFO) will support students at institutions with NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist.&lt;br/&gt;This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.&lt;br /&gt;&lt;a href="mailto:castlea@mail.nih.gov?subject=PA-23-272"&gt;Arthur Castle, Ph.D.&lt;/a&gt;;&lt;a href="mailto:densmorec@mail.nih.gov?subject=PA-23-272"&gt;Christine L Densmore, M.S.&lt;/a&gt;;&lt;a href="mailto:christine.maric-bilkan@nih.gov?subject=PA-23-272"&gt;Christine Maric-Bilkan, Ph.D.&lt;/a&gt;;&lt;a href="mailto:cindy.roy@nih.gov?subject=PA-23-272"&gt;Cindy Roy, Ph.D.&lt;/a&gt; | PA-23-260</description><pubDate>Wed, 16 Aug 2023 09:51:27 -0400</pubDate></item><item><guid isPermaLink="false">{C241B69D-87AE-45AD-82BD-52AED7C7A975}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-23-015</link><title>Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access</title><description>This NOSI aims to support the development of innovative approaches to renal replacement therapy and address critical accompanying challenges such as vascular access and fluid management during dialysis. &lt;br /&gt;&lt;a href="mailto:SEEDinfo@nih.gov?subject=PA-23-232"&gt;NIH SEED (Small business Education and Entrepreneurial Development)&lt;/a&gt; | NOT-DK-23-015</description><pubDate>Mon, 14 Aug 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{9F9E0824-A84D-4E2F-B6D6-F8DFBB258E30}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-248</link><title>Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)</title><description>The purpose of this notice of funding opportunity is to invite Institutional Network Awards (U2C-TL1) to cultivate a highly integrated cohort of trainees and early career investigators and to develop career development resources to accelerate kidney, urologic, and hematologic research. To maximize integration and promote a true trainee community, Institutions are invited to submit a single, unified U2C-TL1 application to engage, recruit, prepare, and sustain the next generation of scientists able to contribute to advancing research in kidney, urology, and hematology. Applications representing multiple institutions within a single metropolitan area are strongly encouraged (see Section III.3).&lt;br /&gt;&lt;a href="mailto:rankint@niddk.nih.gov?subject=PAR-23-248"&gt;Tracy L. Rankin, Ph.D., M.P.H.&lt;/a&gt; | PAR-23-248</description><pubDate>Tue, 01 Aug 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{B31BC606-0B65-4E70-A7E8-D82A6D1D6216}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-219</link><title>SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)</title><description>The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The NOFO aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award.&lt;br/&gt;Clinical Trials are not accepted under this NOFO.&lt;br /&gt;&lt;a href="mailto:daniel.gossett@nih.gov?subject=PAR-23-219"&gt;Daniel Robert Gossett Ph.D.&lt;/a&gt; | PAR-23-219</description><pubDate>Wed, 12 Jul 2023 14:28:32 -0400</pubDate></item><item><guid isPermaLink="false">{7039C04B-9B08-42C9-B636-212F0C836C67}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-23-189</link><title>Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)</title><description>The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project.&lt;br/&gt;This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.&lt;br /&gt;&lt;a href="mailto:riversrc@mail.nih.gov?subject=PA-23-189"&gt;Robert C. Rivers, Ph.D.&lt;/a&gt; | PA-23-189</description><pubDate>Wed, 28 Jun 2023 15:50:50 -0400</pubDate></item></channel></rss>